participants include all T2DM patients with vitamin D insufficiency or deficiency Insulin resistance, cognitive function, Vitamin D, Mindfulness
Conditions
Interventions
The aim of this approach is to invite people to open up to unpleasant feelings, and learn not to overreact to them, and not avoiding situations where they are invoked. Its therapeutic effect is a posi
Experimental Behavioral,Experimental Behavioral,Experimental Dietary Supplement,Placebo Comparator Drug,Placebo Comparator Behavioral
Mindfulness,Mindfulness + Vitamin D,Vitamin D,placebo ,Mindfulness + Placebo
Sponsors
Ethics Committee of Kermanshah University of Medical Sciences
Ethics Committee of Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Subjects are male and female patients aged 18-70 years who are diagnosed with type 2 diabetes mellitus (T2DM) longer than 1 year. 2. Subjects who sign the consent form and can participate in the study until the end of the project.
Exclusion criteria
Exclusion criteria: 1.Subjects with liver kidney and thyroid diseases 2.Subjects with respiratory tract diseases including asthma and chronic obstructive pulmonary disease COPD 3.Subjects with cardiovascular disease including heart failure and coronary artery disease CAD 4.Subjects with symptoms associated with neuromuscular disorders such as dizziness nausea vomiting osteoporosis muscle weakness and spinal stenosis 5.Subjects with chronic infection 6.Subjects who regularly drink alcohol or smoking 7.Subjects who take hormones or nutritional supplements regularly 8.Subjects who were reported that allergy to the ingredients of dietary supplements used in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insulin resistance Before intervention, After intervention HOMA-IR will be Used to Assess Insulin Resistance, and will be Calculated by the Formula | — |
Secondary
| Measure | Time frame |
|---|---|
| Cognitive function Before intervention, After intervention Trail Making Test (TMT),Pain-Related Disability Before intervention, After intervention The Pain Disability Index (PDI),pain severity Before intervention, After intervention The Neuropathic pain scale(NPS) ,Quality of Life Before intervention, After intervention Quality of Life questionnaire (NeuroQol) | — |
Countries
Iran
Contacts
Public Contactmohammadreza davoudi
Central Building of Kermanshah University of Medical Sciences, Shahid Beheshti Blvd, Kermanshah
Outcome results
None listed